Solid Biosciences (SLDB) Prices 21.74M Share Common Offering at $5.75/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Super Micro Computer establishes $1.25 billion stock sale agreement
Pre-Open Stock Movers 03/18: (UPST) (TKAT) (SINO) Higher; (TBIO) (CFRX) (RIDE) Lower (more...)
March 18, 2021 9:31 AM EDTAfter-Hours Stock Movers:
Upstart Holdings. (NASDAQ: UPST) 37% HIGHER; reported Q4 EPS of $0.07, $0.05 better than the analyst estimate of $0.02. Revenue for the quarter came in at $86.7 million versus the consensus estimate of $74.06 million. Upstream Worldwide, Inc. sees Q1 2021 revenue of $112-118 million, versus the consensus of $73.78 million. Upstream Worldwide, Inc. sees FY2021 revenue of $500 million, versus the consensus of $354.3 million.
Takung Art Co., Ltd. (NYSE: TKAT) 33% HIGHER; adds to gains as NFT play
Sino-Global Shipping America, Ltd.... More
After-Hours Stock Movers 03/17: (UPST) (WSM) (FIVE) Higher; (TBIO) (CFRX) (SLDB) Lower (more...)
March 17, 2021 5:40 PM EDTAfter-Hours Stock Movers:
Upstart Holdings. (NASDAQ: UPST) 46% HIGHER; reported Q4 EPS of $0.07, $0.05 better than the analyst estimate of $0.02. Revenue for the quarter came in at $86.7 million versus the consensus estimate of $74.06 million. Upstream Worldwide, Inc. sees Q1 2021 revenue of $112-118 million, versus the consensus of $73.78 million. Upstream Worldwide, Inc. sees FY2021 revenue of $500 million, versus the consensus of $354.3 million.
Translate Bio (Nasdaq: TBIO) 14.5% LOWER; announced results from the second interim... More
Solid Biosciences (SLDB) to Offer $85M in Common Stock
March 17, 2021 4:20 PM EDTSolid Biosciences Inc., (Nasdaq: SLDB) announced that it has commenced an underwritten public offering of $85 million of shares of its common stock. All of the shares are being offered by Solid. In addition, Solid expects to grant the underwriters a 30-day option... More
